| Record ID | marc_loc_2016/BooksAll.2016.part27.utf8:85262763:1009 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part27.utf8:85262763:1009?format=raw |
LEADER: 01009cam a2200289 a 4500
001 98138576
003 DLC
005 20141220091037.0
008 980414s1997 maua b 001 0 eng
010 $a 98138576
020 $a1882615425
040 $aDLC$cDLC$dDLC
043 $an-us---
050 00 $aRA401.A3$bN48 1997
082 00 $a363.19/46/0973$221
100 1 $aMathieu, Mark P.
245 10 $aNew drug development :$ba regulatory overview /$cby Mark Mathieu ; with a contribution from Anne G. Evans.
250 $a4th ed.
260 $aWaltham, MA :$bPAREXEL International Corp.,$cc1997.
300 $aix, 358 p. :$bill. ;$c24 cm.
504 $aIncludes bibliographical references (p. 36-38) and index.
650 0 $aPharmaceutical policy$zUnited States.
610 10 $aUnited States.$bFood and Drug Administration.
650 0 $aDrugs$xLaw and legislation$zUnited States.
650 0 $aPharmaceutical industry$zUnited States.
700 1 $aEvans, Anne G.
710 2 $aParexel International Corporation.